An observational study in Oligospermia, sponsored by Istituto Clinico Humanitas. Completed. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-16.
Sponsored by Istituto Clinico Humanitas · Observational
This is a cohort study including all the first seminal exams performed at the Fertility Center, Humanitas Research Hospital (Rozzano, Milan) between January 1998 and December 2018.
The objective of this study is to evaluate retrospectively different changes of TPMSC during last 20 years in male population who underwent a seminal exam in our Center
64 studies on the registry are indexed under Oligospermia; 17 are open to participants now.
This study's enrollment of 24,395 is above the median of 300 across 17 observational studies indexed under Oligospermia.
Browse Oligospermia studies →Istituto Clinico Humanitas is the lead sponsor of 279 studies on the registry; 70 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Male population who underwent a seminal exam in a tertial fertility care center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
observation
Diagnostic Test: sperm count
total progressive sperm motile count
Mesaurement of changes of sperm count over time
The objective of this study is to evaluate retrospectively different changes of TPMSC during last 20 years in male population who underwent a seminal exam in a tertial fertility care center, regardless of infertility diagnosis.
Time frame: 20 years
No study locations are listed for this record.
Ran from Jan 1999 to primary completion in Dec 2018, 239 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.